Characterization of X chromosome inactivation using integrated analysis of whole-exome and mRNA sequencing.

In females, X chromosome inactivation (XCI) is an epigenetic, gene dosage compensatory mechanism by inactivation of one copy of X in cells. Random XCI of one of the parental chromosomes results in an approximately equal proportion of cells expressing alleles from either the maternally or paternally...

Full description

Bibliographic Details
Main Authors: Szabolcs Szelinger, Ivana Malenica, Jason J Corneveaux, Ashley L Siniard, Ahmet A Kurdoglu, Keri M Ramsey, Isabelle Schrauwen, Jeffrey M Trent, Vinodh Narayanan, Matthew J Huentelman, David W Craig
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4264736?pdf=render
_version_ 1811195309388201984
author Szabolcs Szelinger
Ivana Malenica
Jason J Corneveaux
Ashley L Siniard
Ahmet A Kurdoglu
Keri M Ramsey
Isabelle Schrauwen
Jeffrey M Trent
Vinodh Narayanan
Matthew J Huentelman
David W Craig
author_facet Szabolcs Szelinger
Ivana Malenica
Jason J Corneveaux
Ashley L Siniard
Ahmet A Kurdoglu
Keri M Ramsey
Isabelle Schrauwen
Jeffrey M Trent
Vinodh Narayanan
Matthew J Huentelman
David W Craig
author_sort Szabolcs Szelinger
collection DOAJ
description In females, X chromosome inactivation (XCI) is an epigenetic, gene dosage compensatory mechanism by inactivation of one copy of X in cells. Random XCI of one of the parental chromosomes results in an approximately equal proportion of cells expressing alleles from either the maternally or paternally inherited active X, and is defined by the XCI ratio. Skewed XCI ratio is suggestive of non-random inactivation, which can play an important role in X-linked genetic conditions. Current methods rely on indirect, semi-quantitative DNA methylation-based assay to estimate XCI ratio. Here we report a direct approach to estimate XCI ratio by integrated, family-trio based whole-exome and mRNA sequencing using phase-by-transmission of alleles coupled with allele-specific expression analysis. We applied this method to in silico data and to a clinical patient with mild cognitive impairment but no clear diagnosis or understanding molecular mechanism underlying the phenotype. Simulation showed that phased and unphased heterozygous allele expression can be used to estimate XCI ratio. Segregation analysis of the patient's exome uncovered a de novo, interstitial, 1.7 Mb deletion on Xp22.31 that originated on the paternally inherited X and previously been associated with heterogeneous, neurological phenotype. Phased, allelic expression data suggested an 83∶20 moderately skewed XCI that favored the expression of the maternally inherited, cytogenetically normal X and suggested that the deleterious affect of the de novo event on the paternal copy may be offset by skewed XCI that favors expression of the wild-type X. This study shows the utility of integrated sequencing approach in XCI ratio estimation.
first_indexed 2024-04-12T00:41:17Z
format Article
id doaj.art-00332131dcc3496dab637e89e13e8379
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T00:41:17Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-00332131dcc3496dab637e89e13e83792022-12-22T03:54:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01912e11303610.1371/journal.pone.0113036Characterization of X chromosome inactivation using integrated analysis of whole-exome and mRNA sequencing.Szabolcs SzelingerIvana MalenicaJason J CorneveauxAshley L SiniardAhmet A KurdogluKeri M RamseyIsabelle SchrauwenJeffrey M TrentVinodh NarayananMatthew J HuentelmanDavid W CraigIn females, X chromosome inactivation (XCI) is an epigenetic, gene dosage compensatory mechanism by inactivation of one copy of X in cells. Random XCI of one of the parental chromosomes results in an approximately equal proportion of cells expressing alleles from either the maternally or paternally inherited active X, and is defined by the XCI ratio. Skewed XCI ratio is suggestive of non-random inactivation, which can play an important role in X-linked genetic conditions. Current methods rely on indirect, semi-quantitative DNA methylation-based assay to estimate XCI ratio. Here we report a direct approach to estimate XCI ratio by integrated, family-trio based whole-exome and mRNA sequencing using phase-by-transmission of alleles coupled with allele-specific expression analysis. We applied this method to in silico data and to a clinical patient with mild cognitive impairment but no clear diagnosis or understanding molecular mechanism underlying the phenotype. Simulation showed that phased and unphased heterozygous allele expression can be used to estimate XCI ratio. Segregation analysis of the patient's exome uncovered a de novo, interstitial, 1.7 Mb deletion on Xp22.31 that originated on the paternally inherited X and previously been associated with heterogeneous, neurological phenotype. Phased, allelic expression data suggested an 83∶20 moderately skewed XCI that favored the expression of the maternally inherited, cytogenetically normal X and suggested that the deleterious affect of the de novo event on the paternal copy may be offset by skewed XCI that favors expression of the wild-type X. This study shows the utility of integrated sequencing approach in XCI ratio estimation.http://europepmc.org/articles/PMC4264736?pdf=render
spellingShingle Szabolcs Szelinger
Ivana Malenica
Jason J Corneveaux
Ashley L Siniard
Ahmet A Kurdoglu
Keri M Ramsey
Isabelle Schrauwen
Jeffrey M Trent
Vinodh Narayanan
Matthew J Huentelman
David W Craig
Characterization of X chromosome inactivation using integrated analysis of whole-exome and mRNA sequencing.
PLoS ONE
title Characterization of X chromosome inactivation using integrated analysis of whole-exome and mRNA sequencing.
title_full Characterization of X chromosome inactivation using integrated analysis of whole-exome and mRNA sequencing.
title_fullStr Characterization of X chromosome inactivation using integrated analysis of whole-exome and mRNA sequencing.
title_full_unstemmed Characterization of X chromosome inactivation using integrated analysis of whole-exome and mRNA sequencing.
title_short Characterization of X chromosome inactivation using integrated analysis of whole-exome and mRNA sequencing.
title_sort characterization of x chromosome inactivation using integrated analysis of whole exome and mrna sequencing
url http://europepmc.org/articles/PMC4264736?pdf=render
work_keys_str_mv AT szabolcsszelinger characterizationofxchromosomeinactivationusingintegratedanalysisofwholeexomeandmrnasequencing
AT ivanamalenica characterizationofxchromosomeinactivationusingintegratedanalysisofwholeexomeandmrnasequencing
AT jasonjcorneveaux characterizationofxchromosomeinactivationusingintegratedanalysisofwholeexomeandmrnasequencing
AT ashleylsiniard characterizationofxchromosomeinactivationusingintegratedanalysisofwholeexomeandmrnasequencing
AT ahmetakurdoglu characterizationofxchromosomeinactivationusingintegratedanalysisofwholeexomeandmrnasequencing
AT kerimramsey characterizationofxchromosomeinactivationusingintegratedanalysisofwholeexomeandmrnasequencing
AT isabelleschrauwen characterizationofxchromosomeinactivationusingintegratedanalysisofwholeexomeandmrnasequencing
AT jeffreymtrent characterizationofxchromosomeinactivationusingintegratedanalysisofwholeexomeandmrnasequencing
AT vinodhnarayanan characterizationofxchromosomeinactivationusingintegratedanalysisofwholeexomeandmrnasequencing
AT matthewjhuentelman characterizationofxchromosomeinactivationusingintegratedanalysisofwholeexomeandmrnasequencing
AT davidwcraig characterizationofxchromosomeinactivationusingintegratedanalysisofwholeexomeandmrnasequencing